Also trades as: 0809.HK (HKSE) · $vol 0M
GBCMY OTC
Global Bio-chem Technology Group Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -15.0%
1Y: -15.0%
3Y: -55.0%
$4.14
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.3B
+13.7% ▲
5Y CAGR: +21.8%
Gross Profit
$196M
-10.3% ▼
5Y CAGR: +21.5%
Operating Income
-$78M
+43.9% ▲
Net Income
$156M
-79.7% ▼
EPS (Diluted)
$0.28
-93.5% ▼
EBITDA
$35M
+108.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $747M | $13M | $1.4B | $2.0B | $2.3B |
| YoY Growth | -12.1% | -98.3% | +10709.0% | +45.6% | +13.7% |
| Cost of Revenue | $698M | $338M | $1.3B | $1.8B | $2.1B |
| Gross Profit | $48M | $8M | $44M | $219M | $196M |
| Gross Margin | 6.5% | 62.1% | 3.2% | 10.9% | 8.6% |
| R&D Expenses | $13M | $10M | $6M | $4M | $8M |
| SG&A Expenses | $436M | $268M | $370M | $354M | $295M |
| Operating Expenses | $431M | $278M | $370M | $358M | $274M |
| Operating Income | -$388M | -$270M | -$318M | -$140M | -$78M |
| Operating Margin | -52.0% | -2122.9% | -23.2% | -7.0% | -3.4% |
| Interest Expense | $791M | $685M | $750M | $323M | $308M |
| Income Before Tax | -$409M | -$1.4B | $3.7B | $746M | $156M |
| Tax Expense | $26M | -$47M | -$42M | -$24M | $110K |
| Net Income | -$401M | -$1.4B | $4.2B | $770M | $156M |
| Net Margin | -53.7% | -11352.9% | 307.5% | 38.5% | 6.9% |
| EPS (Diluted) | $-2.25 | $-8.00 | $23.50 | $4.30 | $0.28 |
| EBITDA | $786M | -$469M | -$43M | $17M | $35M |
| Shares Outstanding | 178M | 178M | 178M | 179M | 562M |